CJC-1295 DAC Peptide Overview

CJC-1295 DAC is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) studied for its potential role in stimulating growth hormone pathways. It consists of 29 amino acids and includes a Drug Affinity Complex (DAC) modification designed to improve stability and extend its half-life compared to non-DAC versions.

The DAC component helps increase peptide stability by enhancing its interaction with plasma proteins, allowing for longer activity in research models.

Research Overview

CJC-1295 DAC has been studied for its potential effects on:

• Growth hormone signaling: Research focuses on its interaction with GHRH receptors and growth hormone release pathways.
• Body composition: Investigated for its relationship with fat metabolism and lean tissue support.
• Bone and connective tissue research: Studied in relation to growth hormone-related pathways.
• Sleep and recovery pathways: Explored for its potential role in GHRH-related biological processes.

CJC-1295 DAC is also researched alongside other peptides, including Ipamorelin, to study combined effects on growth hormone signaling.

Chemical Information

• Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• Molecular Weight: 3367.95 g/mol
• Other Names: Tetrasubstituted GRF 1-29 with DAC, Long-acting GHRH Analog